GlassScriptPhysician profile
Kunal Chaudhry
NPI 1114138815
$11,577.43
in general payments reported to CMS, 2019-2025
20 companies · $434 in 2025
The $434 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,117 · 2020: $3,469 · 2021: $442 · 2022: $580 · 2023: $1,597 · 2024: $938 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,918 · Consulting Fee: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,918.47 |
| Consulting Fee | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $6,318.91 | 2019-2022 | |
| Abbott Laboratories | $1,846.81 | 2019-2024 | Amplatzer Amulet, Navitor, Aveir |
| Boston Scientific Corporation | $630.14 | 2020-2025 | Watchman Access System, Watchman Flx |
| Medtronic, INC. | $595.15 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra, Sprinter Legend |
| Edwards Lifesciences Corporation | $594.49 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $428.40 | 2019-2023 | Impella |
| Medtronic Vascular, INC. | $345.77 | 2019-2020 | |
| Biosense Webster, INC. | $183.15 | 2023-2024 | Nuvision Ice Catheter, Na, Soundstar |
| Atricure, INC. | $154.70 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $149.04 | 2019-2023 | Lifevest |
| Amgen INC. | $70.76 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $65.51 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $36.89 | 2024 | Assure Wcd |
| Cardinal Health 200 LLC | $28.44 | 2019 | |
| Cvrx, INC. | $27.44 | 2024-2025 | Barostim Neo System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $26.41 | 2025 | Camzyos |
| Pfizer INC. | $19.51 | 2025 | |
| Siemens Medical Solutions USA, INC. | $19.06 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.57 | 2023 | Xarelto |
| Penumbra, INC. | $18.28 | 2024 | Indigo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.